Fig. 1

Analysis of total cholesterol (TC) before NAC and overall survival (OS) in patients with all breast cancer subtypes. OS was not significantly different between patients with normal TC and high TC levels among all breast cancer (P = 0.388, log-rank) (a). OS was not significantly different between patients with normal TC and high TC levels in luminal breast cancer (P = 0.108, log-rank) (b). OS was not significantly different between patients with normal TC and high TC levels in luminal-human-epidermal growth factor receptor 2 (HER2)-enriched breast cancer (P = 0.801, log-rank) (c). Patients with normal TC before NAC had significantly better OS of HER2-enriched (P = 0.013, log-rank) (d). OS was not significantly different between patients with normal TC and high TC levels in triple-negative breast cancer (P = 0.075, log-rank) (e)